Fifth Third Bancorp
CLYM

Fifth Third Bancorp’s Climb Bio CLYM Stock Holding History

Fifth Third Bancorp’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Buy
+164,923
New +$1.7M ﹤0.01% 1220

Other funds holding CLYM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Fifth Third Bancorp's CLYM Position: Q2 2026 in Review

Fifth Third Bancorp opened a new position in Climb Bio (CLYM) in Q2 2026: 164,923 shares worth $2.15M. The stake represents ﹤0.01% of the portfolio and ranks #1220 among its holdings.

22 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Fifth Third Bancorp held 164,923 shares of Climb Bio worth $2.15M as of Q2 2026.
  • Climb Bio was a new Fifth Third Bancorp position in Q2 2026.
  • Climb Bio made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1220 holding.
  • 22 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.